(6-Chlorobenzo[d]isoxazol-3-yl)methanamine
|
- $299 - $2469
- Product name: (6-Chlorobenzo[d]isoxazol-3-yl)methanamine
- CAS: 1314932-51-8
- MF: C8H7ClN2O
- MW: 182.61
- EINECS:
- MDL Number:MFCD09029022
- Synonyms:1,2-Benzisoxazole-3-methanamine, 6-chloro-;(6-Chlorobenzo[d]isoxazol-3-yl)methanamine
5 prices
Selected condition:
Brand
- aablocks
- Chemenu
- Crysdot
Package
- 50mg
- 250mg
- 1g
- Manufactureraablocks
- Product numberAA01BIGV
- Product description(6-CHLOROBENZO[D]ISOXAZOL-3-YL)METHANAMINE 97%
- Packaging50mg
- Price$299
- Updated2026-05-29
- Buy
- Manufactureraablocks
- Product numberAA01BIGV
- Product description(6-CHLOROBENZO[D]ISOXAZOL-3-YL)METHANAMINE 97%
- Packaging250mg
- Price$799
- Updated2026-05-29
- Buy
- Manufactureraablocks
- Product numberAA01BIGV
- Product description(6-CHLOROBENZO[D]ISOXAZOL-3-YL)METHANAMINE 97%
- Packaging1g
- Price$2469
- Updated2026-05-29
- Buy
- ManufacturerChemenu
- Product numberCM219788
- Product description(6-Chlorobenzo[d]isoxazol-3-yl)methanamine 97%
- Packaging1g
- Price$1198
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11295803
- Product description(6-Chlorobenzo[d]isoxazol-3-yl)methanamine 97%
- Packaging1g
- Price$1271
- Updated2026-05-26
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01BIGV | (6-CHLOROBENZO[D]ISOXAZOL-3-YL)METHANAMINE 97% | 50mg | $299 | 2026-05-29 | Buy |
| aablocks | AA01BIGV | (6-CHLOROBENZO[D]ISOXAZOL-3-YL)METHANAMINE 97% | 250mg | $799 | 2026-05-29 | Buy |
| aablocks | AA01BIGV | (6-CHLOROBENZO[D]ISOXAZOL-3-YL)METHANAMINE 97% | 1g | $2469 | 2026-05-29 | Buy |
| Chemenu | CM219788 | (6-Chlorobenzo[d]isoxazol-3-yl)methanamine 97% | 1g | $1198 | 2021-12-16 | Buy |
| Crysdot | CD11295803 | (6-Chlorobenzo[d]isoxazol-3-yl)methanamine 97% | 1g | $1271 | 2026-05-26 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




